首页> 外文期刊>Biomaterials Science >A liquid crystalline precursor incorporating chlorhexidine acetate and silver nanoparticles for root canal disinfection
【24h】

A liquid crystalline precursor incorporating chlorhexidine acetate and silver nanoparticles for root canal disinfection

机译:含有氯己定乙酸酯和银纳米粒子的液晶前体,用于根管消毒

获取原文
获取原文并翻译 | 示例
           

摘要

Lyotropic liquid crystals (LLC) have received increasing attention as a drug delivery system. In this study, a novel intra-canal disinfectant based on the glycerol monooleate (GMO) LLC precursor incorporation with chlorhexidine (CHX) and silver nanoparticles (Ag-NPs) was designed and evaluated. The LLC precursor with excellent fluidity was able to penetrate deeply into the complex tiny collateral branch root canals. The transformation of cubic LLC in root canals upon coming into contact with water provided long-lasting disinfection against multidrug-resistant bacteria to avoid the endodontic reinfection and follow-up visits. The GMO-ethanol-water (48% :12% : 40%, w/w) formulation containing 0.5% CHX and 0.02% AgNPs was selected for further studies. The low viscosity of the precursor presented excellent injectability and flowabilities. From the in vitro release test, the release behaviours were found to be influenced by CHX and Ag-NP contents, allowing the optimized precursor to obtain a 28-day release profile. The CHX-Ag-NP containing LLC precursor exhibited an excellent and sustained sterilization effect on Enterococcus faecalis for more than one month with a bacterial inactivation rate of 98.5%, which was far more than the minimum clinical requirement (7 days). Furthermore, no in vitro toxicity was observed in the cytotoxicity evaluation. The CHX-Ag-NP containing LLC precursor was proved to be a promising intra-canal disinfectant in our study.
机译:Lyotropic液晶(LLC)因药物输送系统而受到越来越多的关注。在该研究中,设计并评估了基于甘油单烯烃(GMO)LLC前体(GMO)LLC前体(GMO)和银纳米颗粒(AG-NPS)的新型管内消毒剂。具有优异的流动性的LLC前体能够深入渗透到复杂的微小侧枝根管中。在与水接触后,立方体LLC在根系中的转化提供了对多药抗性细菌的长期消毒,以避免牙髓性重新感染和后续访问。含有0.5%CHX和0.02%AgNP的转基因 - 乙醇 - 水(48%:12%:40%,W / W)制剂用于进一步研究。前体的低粘度呈现出优异的可注射性和流量。从体外释放试验中,发现释放行为受CHX和AG-NP含量的影响,允许优化的前体获得28天的释放曲​​线。含有LLC前体的CHX-AG-NP对肠球菌粪便的优异且持续的灭菌效果超过一个月,细菌灭活率为& 98.5%,远远超过最低临床要求(7天)。此外,在细胞毒性评价中没有观察到体外毒性。含有LLC前体的CHX-AG-NP被证明是我们研究中的通用管内消毒剂。

著录项

  • 来源
    《Biomaterials Science》 |2018年第3期|共8页
  • 作者单位

    Sun Yat Sen Univ Sch Pharmaceut Sci Guangzhou 510006 Guangdong Peoples R China;

    Sinohlth Intelligence Co Ltd Guangzhou 510006 Guangdong Peoples R China;

    Sun Yat Sen Univ Sch Pharmaceut Sci Guangzhou 510006 Guangdong Peoples R China;

    Sun Yat Sen Univ Sch Pharmaceut Sci Guangzhou 510006 Guangdong Peoples R China;

    Sun Yat Sen Univ Sch Pharmaceut Sci Guangzhou 510006 Guangdong Peoples R China;

    Sun Yat Sen Univ Sch Pharmaceut Sci Guangzhou 510006 Guangdong Peoples R China;

    Sun Yat Sen Univ Sch Pharmaceut Sci Guangzhou 510006 Guangdong Peoples R China;

    Sun Yat Sen Univ Sch Pharmaceut Sci Guangzhou 510006 Guangdong Peoples R China;

    Sun Yat Sen Univ Sch Pharmaceut Sci Guangzhou 510006 Guangdong Peoples R China;

    Sun Yat Sen Univ Sch Pharmaceut Sci Guangzhou 510006 Guangdong Peoples R China;

    Sun Yat Sen Univ Sch Pharmaceut Sci Guangzhou 510006 Guangdong Peoples R China;

    Univ Surrey Fac Engn &

    Phys Sci J2 Dept Chem &

    Proc Engn Guildford GU2 7XH Surrey England;

    Sun Yat Sen Univ Sch Pharmaceut Sci Guangzhou 510006 Guangdong Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 分子生物学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号